Clinical Trial Update: The Efficacy and Safety of Nelarabine Injection in Patients With T-lymphoblastic Leukemia and T-lymphoblastic Lymphoma [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating nelarabine for T-lymphoblastic leukemia and T-lymphoblastic lymphoma is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• T-lymphoblastic Leukemia
• T-lymphoblastic Lymphoma

Drugs mentioned

• Nelarabine (Nelarabine)

Snippet

Sponsor: Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | Conditions: T-lymphoblastic Leukemia, T-lymphoblastic Lymphoma | Phase 3 | Status: NOT_YET_RECRUITING